Biotage AB (BIOT) Rise 1.47% on Oct 21

October 21, 2017 - By Peter Erickson

Shares of Biotage AB (STO:BIOT) last traded at 69, representing a move of 1.47%, or 1 per share, on volume of 47,081 shares. After opening the trading day at 68.25, shares of Biotage AB traded in a close range. Biotage AB currently has a total float of 64.71M shares and on average sees 75,821 shares exchange hands each day. The stock now has a 52-week low of 38.5 and high of 72.5.

Getting To Know The OMXS30

Sweden is a uniquely powerful economy in Europe just like Germany, France, and other thriving European economies. Its rich equity market is a proof of its excellent corporate governance that every investor is looking for when it comes to foreign investments. They are looking for Biotage AB to check its reliability.

The Swedish Equity Market

The Stockholm Stock Exchange, commonly known as Nasdaq Stockholm, is the main stock exchange in Sweden situated in Frihamnen, Stockholm. Biotage AB is one of the NASDAQ most active participants. It is operated by Nasdaq Nordiq, a 13-year-old subsidiary of Nasdaq, Inc.

Nasdaq Nordiq was established in 2003 for the primary purpose of overseeing the stock exchanges in Nordic countries. Aside from the Nasdaq Stockholm, it also operates the Tallinn Stock Exchange, commonly known as Nasdaq Baltic; the Riga Stock Exchange, commonly known as Nasdaq Baltic; the Iceland Stock Exchange, commonly known as Nasdaq Iceland; the Helsinki Stock Exchange, commonly known as Nasdaq Helsinki; the Copenhagen Stock Exchange, commonly known as Nasdaq Copenhagen; and the Armenia Stock Exchange, commonly known as Nasdaq OMX Armenia.

The Nasdaq Stockholm has been present since 1863, making it one of the oldest European stock exchanges. It has only adopted electronic trading on June 1, 1990. Prior to this, floor trading had happened at the Stockholm Stock Exchange Building.

The regular session on the Nasdaq Stockholm commences from 9:00 a.m. until 5:00 p.m. every business day. That is the time for Biotage AB to count its gain.

The OMX Stockholm 30 Index (OMXS30) is the market-capitalization-weighted index that monitors the 30 most active stocks on the Nasdaq Stockholm. Numerous sectors make up the OMXS30; and the top three largest sectors are Industrials, Financials, and Consumer Services. Being the benchmark index in Sweden, it is a crucial indicator of the Swedish economy.

The OMXS30 is rebalanced twice a year, ensuring a strong indication of how well the Swedish equity market is. As such, some components may be dropped to give way to other companies that are more competitive. Several factors such as liquidity, market capitalization, and industry representation play major role in a stock’s inclusion to the OMXS30.

By the Numbers

As of the end of the first quarter of 2016, the Nasdaq Stockholm has a market capitalization of nearly $1.30 trillion with over 300 stocks listed on it.

Meanwhile, the OMXS30 holds an all-time low of 98.86 points, which was last seen in November 1987. Sweden is one of the many countries that had suffered from Black Monday, a remarkable global equity market meltdown in history that began with the sinking of stocks on the Stock Exchange of Hong Kong (HK).

Gradually, the Swedish economy was able to overcome all other challenges through the years. In April 2015, the OMXS30 had reached an all-time high of 1,719.93 points.

The Nasdaq Stockholm is one of the most valuable and most competitive stock exchanges in Europe. Because of an attractive borrowing environment in European Union (EU) countries such as Sweden, many investors are flocking the Swedish equity market. There is no better way to take advantage of these growth opportunities than to invest in European stocks such as those listed on the Nasdaq Stockholm. And look for Biotage AB advantages.

More recent Biotage AB (STO:BIOT) news were published by: Globenewswire.com which released: “Biotage AB (publ) – board member Anders Walldov leaves his assignments” on June 01, 2016. Also Businesswire.com published the news titled: “Biotage AB Acquires MIP Technologies AB, Developer of Molecularly Imprinted …” on April 26, 2010. Businesswire.com‘s news article titled: “Biotage invests in biomolecule purification” with publication date: August 31, 2016 was also an interesting one.

Biotage AB is a Sweden-based company that develops and sells systems, consumables and services in the field of life sciences. The company has market cap of $4.47 billion. The Company’s clients include pharmaceutical and biotechnology companies, companies within the food industry and academic institutions. It has a 37.79 P/E ratio. The Firm offers systems and services within three areas: analytical chemistry, organic chemistry and industrial resins.